Cancer Communications
indexed by SCI

About the cover
About the cover

Feb. 2014; Volume 33 Issue 2

February 27, 2004, Roche announced that Genentech has received approval from the US Food and Drug Administration (FDA) for Avastin (bevacizumab, rhuMAb-VEGF), an innovative new cancer drug, to be used with intravenous 5-Fluorouracil-based chemotherapy as treatment for patients with previously untreated metastatic cancer of the colon or rectum (first-line treatment).

Resistance to apoptosis should not be taken as a hallmark of cancer
Rui-An Wang, Zeng-Shan Li, Qing-Guo Yan, Xiu-Wu Bian, Yan-Qing Ding, Xiang Du, Bao-Cun Sun, Yun-Tian Sun, Xiang-Hong Zhang
[ Abstract  2486]   [ PDF Full-text  2028]     [ HTML PMC ]  Page: 47-50  Epub: 2013-12-24  doi: 10.5732/cjc.013.10131
The role of maintenance proteins in the preservation of epithelial cell identity during mammary gland remodeling and breast cancer initiation
Danila Coradini, Saro Oriana
[ Abstract  2660]   [ PDF Full-text  2873]     [ HTML PMC ]  Page: 51-67  Epub: 2013-7-12  doi: 10.5732/cjc.013.10040
Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population
Hong-Li Xu, Jia-Rong Cheng, Wei Zhang, Jing Wang, Herbert Yu, Quan-Xing Ni, Harvey A. Risch, Yu-Tang Gao
[ Abstract  2501]   [ PDF Full-text  2201]     [ HTML PMC ]  Page: 68-73  Epub: 2013-7-2  doi: 10.5732/cjc.013.10060
Vasculogenic mimicry: a novel target for glioma therapy
Yin-Sheng Chen, Zhong-Ping Chen
[ Abstract  3342]   [ PDF Full-text  3529]     [ HTML PMC ]  Page: 74-79  Epub: 2013-7-2  doi: 10.5732/cjc.012.10292
Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
Christopher P. Guise, Alexandra M. Mowday, Amir Ashoorzadeh, Ran Yuan, Wan-Hua Lin, Dong-Hai Wu, Jeff B. Smaill, Adam V. Patterson, Ke Ding
[ Abstract  3698]   [ PDF Full-text  4502]     [ HTML PMC ]  Page: 80-86  Epub: 2013-7-12  doi: 10.5732/cjc.012.10285
Original Article
Pancreatic pseudocyst or a cystic tumor of the pancreas?
Mohammad Ezzedien Rabie, Ismail El Hakeem, Mohammad Saad Al Skaini, Ahmad El Hadad, Salim Jamil, Mian Tahir Shah, Mahmoud Obaid
[ Abstract  2427]   [ PDF Full-text  2787]     [ HTML PMC ]  Page: 87-95  Epub: 2013-8-6  doi: 10.5732/cjc.012.10296
High plasma fibrinogen concentration and platelet count unfavorably impact survival in non–small cell lung cancer patients with brain metastases
Jian-Fei Zhu, Ling Cai, Xue-Wen Zhang, Yin-Sheng Wen, Xiao-Dong Su, Tie-Hua Rong, Lan-Jun Zhang
[ Abstract  3079]   [ PDF Full-text  3212]     [ HTML PMC ]  Page: 96-104  Epub: 2013-8-19  doi: 10.5732/cjc.012.10307
The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
Jian-Wei Zhang, Yuan-Yuan Zhao, Ying Guo, Cong Xue, Zhi-Huang Hu, Yan Huang, Hong-Yun Zhao, Jing Zhang, Xuan Wu, Wen-Feng Fang, Yu-Xiang Ma, Li Zhang
[ Abstract  2618]   [ PDF Full-text  2210]     [ HTML PMC ]  Page: 105-114  Epub: 2013-7-2  doi: 10.5732/cjc.012.10274
Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
Zhi-Kun Qiu, Dong Shen, Yin-Sheng Chen, Qun-Ying Yang, Cheng-Cheng Guo, Bing-Hong Feng, Zhong-Ping Chen
[ Abstract  2671]   [ PDF Full-text  2776]     [ HTML PMC ]  Page: 115-122  Epub: 2013-8-6  doi: 10.5732/cjc.012.10236

CC Wechat 微信公众号


Editorial Manager

CC adopts Editorial Manager to manage its submissions from Dec.18, 2014


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China